FDAClass II · Drug · Recalled May 20, 2026

Ascend Laboratories recall — Ascend Laboratories, LLC

Hazard: Failed Dissolution Specifications

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID: D-0547-2026
Brand: Ascend Laboratories
Classification: Class II
Units affected: 17,304 100-count bottles
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Description

Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.

Affected products

Ascend Laboratories

Companies & origin

Recalling firm location: Bedminster, NJ, United States
Firm address: 135 Us Highway 202 206 Ste 15, 07921-2608

Identifying details (verbatim from the notice)

Product codes / lots: Lot # 25140859; Exp. Date: Jan 2027
Distribution: U.S. Nationwide
Firm notified the public via: Letter
FDA event ID: 98821
Recall initiated: April 27, 2026
FDA classified: May 20, 2026
FDA report date: May 20, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 24, 2026 at 12:00 AM UTC.

Report a data error on this page